Athanasia Alexoudi

Circulating miR‐146a and miR‐134 in predicting drug‐resistant epilepsy in patients with focal impaired awareness seizures

Maria Leontariti, Margaritis Avgeris, Martha‐Spyridoula Katsarou et al. · Epilepsia · 2020 · 52 citations

The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus

Ali Shalash, Athanasia Alexoudi, Karina Knudsen et al. · Parkinsonism & Related Disorders · 2013 · 45 citations · Full text

Disease Duration, Neurodegenerative Diseases, Corticobasal Degeneration +11

Spastic paraplegia preceding <i>PSEN1</i>‐related familial Alzheimer's disease

Viorica Chelban, Marianthi Breza, María Szaruga et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2021 · 20 citations · Full text

Possible Implication of GSTP1 and NQO1 Polymorphisms on Natalizumab Response in Multiple Sclerosis.

Athanasia Alexoudi, Sophia Zachaki, Chrysa Stavropoulou et al. · PubMed · 2016 · 19 citations

Natalizumab Administration, Disease Progression, Immunology +18

The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease

Chrysa Stavropoulou, Sophia Zachaki, Athanasia Alexoudi et al. · Free Radical Biology and Medicine · 2011 · 18 citations

Disease Susceptibility, Medicine, Genetics +12